Progress towards the UNAIDS 90‐90‐90 targets among persons aged 50 and older living with HIV in 13 African countries

Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa...

Full description

Saved in:
Bibliographic Details
Published inJournal of the International AIDS Society Vol. 25; no. S4; pp. e26005 - n/a
Main Authors Farley, Shannon M., Wang, Chunhui, Bray, Rachel M., Low, Andrea Jane, Delgado, Stephen, Hoos, David, Kakishozi, Angela N., Harris, Tiffany G., Nyirenda, Rose, Wadonda, Nellie, Li, Michelle, Amuri, Mbaraka, Juma, James, Kancheya, Nzali, Pietersen, Ismela, Mutenda, Nicholus, Natanael, Salomo, Aoko, Appolonia, Ngugi, Evelyn W., Asiimwe, Fred, Lecher, Shirley, Ward, Jennifer, Chikwanda, Prisca, Mugurungi, Owen, Moyo, Brian, Nkurunziza, Peter, Aibo, Dorothy, Kabala, Andrew, Biraro, Sam, Ndagije, Felix, Musuka, Godfrey, Ndongmo, Clement, Shang, Judith, Dokubo, Emily K., Dimite, Laura E., McCullough‐Sanden, Rachel, Bissek, Anne‐Cecile, Getaneh, Yimam, Eshetu, Frehywot, Nkumbula, Tepa, Tenthani, Lyson, Kayigamba, Felix R., Kirungi, Wilford, Musinguzi, Joshua, Balachandra, Shirish, Kayirangwa, Eugenie, Ayite, Ayiyi, West, Christine A., Bodika, Stephane, Sleeman, Katrina, Patel, Hetal K., Brown, Kristin, Voetsch, Andrew C., El‐Sadr, Wafaa M., Justman, Jessica J.
Format Journal Article
LanguageEnglish
Published Geneva John Wiley & Sons, Inc 01.09.2022
John Wiley and Sons Inc
Subjects
Acquired immune deficiency syndrome
Age groups
ageing
AIDS
AIDS (Disease)
AIDS research
Antiretroviral agents
Care and treatment
Demographic aspects
Demographics
Evaluation
Health status indicators
HIV
HIV epidemiology
HIV infection
HIV testing
Households
Human immunodeficiency virus
Laboratories
Older people
older PLHIV
PHIA
Population
Public health administration
Self report
UNAIDS goals
Women
Africa
Cameroon
United States > US
Rwanda
Tanzania
Zambia
Ivory Coast
California
Kenya
San Francisco California
Eswatini
Malawi
Namibia
Zimbabwe
Uganda
Lesotho
Ethiopia
Online AccessGet full text

Cover

Abstract Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90‐90‐90 progress by age, 15–49 (as a comparison) and 50+ years, with further analyses among 50+ (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Methods Using data from nationally representative Population‐based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90‐90‐90 targets. Country‐specific Poisson regression models examined 90‐90‐90 variation among OPLWH age strata. Results Analyses included 24,826 HIV‐positive individuals (15–49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15–49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15–49, women were more likely to achieve 90‐90‐90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country‐specific 90‐90‐90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. Conclusions While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV‐positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
AbstractList INTRODUCTIONAchieving optimal HIV outcomes, as measured by global 90-90-90 targets, that is awareness of HIV-positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub-Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90-90-90 progress by age, 15-49 (as a comparison) and 50+ years, with further analyses among 50+ (55-59, 60-64, 65+ vs. 50-54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). METHODSUsing data from nationally representative Population-based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90-90-90 targets. Country-specific Poisson regression models examined 90-90-90 variation among OPLWH age strata. RESULTSAnalyses included 24,826 HIV-positive individuals (15-49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15-49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15-49, women were more likely to achieve 90-90-90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country-specific 90-90-90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. CONCLUSIONSWhile OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV-positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90‐90‐90 progress by age, 15–49 (as a comparison) and 50+ years, with further analyses among 50+ (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Using data from nationally representative Population‐based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90‐90‐90 targets. Country‐specific Poisson regression models examined 90‐90‐90 variation among OPLWH age strata. Analyses included 24,826 HIV‐positive individuals (15–49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15–49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15–49, women were more likely to achieve 90‐90‐90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country‐specific 90‐90‐90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV‐positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Abstract Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90‐90‐90 progress by age, 15–49 (as a comparison) and 50+ years, with further analyses among 50+ (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Methods Using data from nationally representative Population‐based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90‐90‐90 targets. Country‐specific Poisson regression models examined 90‐90‐90 variation among OPLWH age strata. Results Analyses included 24,826 HIV‐positive individuals (15–49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15–49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15–49, women were more likely to achieve 90‐90‐90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country‐specific 90‐90‐90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. Conclusions While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV‐positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Introduction: Achieving optimal HIV outcomes, as measured by global 90?90?90 targets, that is awareness of HIV?positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub?Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90?90?90 progress by age, 15?49 (as a comparison) and 50+ years, with further analyses among 50+ (55?59, 60?64, 65+ vs. 50?54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Methods: Using data from nationally representative Population?based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90?90?90 targets. Country?specific Poisson regression models examined 90?90?90 variation among OPLWH age strata. Results: Analyses included 24,826 HIV?positive individuals (15?49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15?49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15?49, women were more likely to achieve 90?90?90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country?specific 90?90?90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. Conclusions: While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV?positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90‐90‐90 progress by age, 15–49 (as a comparison) and 50+ years, with further analyses among 50+ (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Methods Using data from nationally representative Population‐based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90‐90‐90 targets. Country‐specific Poisson regression models examined 90‐90‐90 variation among OPLWH age strata. Results Analyses included 24,826 HIV‐positive individuals (15–49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15–49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15–49, women were more likely to achieve 90‐90‐90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country‐specific 90‐90‐90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. Conclusions While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV‐positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Audience Academic
Author Chikwanda, Prisca
El‐Sadr, Wafaa M.
Mugurungi, Owen
Getaneh, Yimam
Low, Andrea Jane
Aibo, Dorothy
Kakishozi, Angela N.
Voetsch, Andrew C.
Kayigamba, Felix R.
Asiimwe, Fred
Justman, Jessica J.
Ndagije, Felix
Shang, Judith
Musinguzi, Joshua
Juma, James
Hoos, David
Nkurunziza, Peter
Pietersen, Ismela
Harris, Tiffany G.
Wadonda, Nellie
Nkumbula, Tepa
Delgado, Stephen
Tenthani, Lyson
Aoko, Appolonia
Balachandra, Shirish
Moyo, Brian
Kirungi, Wilford
Kabala, Andrew
Bissek, Anne‐Cecile
Dimite, Laura E.
Kancheya, Nzali
Patel, Hetal K.
Wang, Chunhui
McCullough‐Sanden, Rachel
Amuri, Mbaraka
Ayite, Ayiyi
Eshetu, Frehywot
Sleeman, Katrina
Natanael, Salomo
Nyirenda, Rose
Biraro, Sam
Dokubo, Emily K.
Musuka, Godfrey
Mutenda, Nicholus
Kayirangwa, Eugenie
Farley, Shannon M.
Bray, Rachel M.
Bodika, Stephane
Li, Michelle
Lecher, Shirley
Ward, Jennifer
Brown, Kristin
Ndongmo, Clement
West, Christine A.
Ngugi, Evelyn W.
AuthorAffiliation 19 CDC Addis Ababa Ethiopia
7 Ministry of Health Community Development Gender, Elderly and Children through The National AIDS Control Program (NACP) Dodoma Tanzania
9 CDC Windhoek Namibia
10 Ministry of Health and Social Services Windhoek Namibia
13 CDC Kampala Uganda
20 Uganda Ministry of Health Kampala Uganda
6 CDC Dar es Salaam Tanzania
14 CDC Harare Zimbabwe
18 Ethiopia Public Health Institute Addis Ababa Ethiopia
2 Department of Epidemiology Mailman School of Public Health Columbia University New York City New York USA
17 Cameroon Ministry of Public Health Yaounde Cameroon
22 CDC Kigali Rwanda
4 US Centers for Disease Control and Prevention (CDC) Lilongwe Malawi
16 CDC Yaounde Cameroon
5 CDC Mbabane Eswatini
21 CDC Abidjan Cote d'Ivoire
3 Malawi Ministry of Health Lilongwe Malawi
23 CDC Atlanta Georgia USA
8 CDC Lusaka Zambia
15 Zimbabwe Ministry of Health and Child Care Hararre Zimbabwe
12 CDC Maseru Lesotho
11 CDC Nairobi Kenya
1 ICAP at Columbia University New York City New York USA
AuthorAffiliation_xml – name: 9 CDC Windhoek Namibia
– name: 10 Ministry of Health and Social Services Windhoek Namibia
– name: 4 US Centers for Disease Control and Prevention (CDC) Lilongwe Malawi
– name: 12 CDC Maseru Lesotho
– name: 19 CDC Addis Ababa Ethiopia
– name: 2 Department of Epidemiology Mailman School of Public Health Columbia University New York City New York USA
– name: 18 Ethiopia Public Health Institute Addis Ababa Ethiopia
– name: 6 CDC Dar es Salaam Tanzania
– name: 17 Cameroon Ministry of Public Health Yaounde Cameroon
– name: 13 CDC Kampala Uganda
– name: 14 CDC Harare Zimbabwe
– name: 8 CDC Lusaka Zambia
– name: 15 Zimbabwe Ministry of Health and Child Care Hararre Zimbabwe
– name: 20 Uganda Ministry of Health Kampala Uganda
– name: 23 CDC Atlanta Georgia USA
– name: 5 CDC Mbabane Eswatini
– name: 11 CDC Nairobi Kenya
– name: 21 CDC Abidjan Cote d'Ivoire
– name: 1 ICAP at Columbia University New York City New York USA
– name: 7 Ministry of Health Community Development Gender, Elderly and Children through The National AIDS Control Program (NACP) Dodoma Tanzania
– name: 22 CDC Kigali Rwanda
– name: 16 CDC Yaounde Cameroon
– name: 3 Malawi Ministry of Health Lilongwe Malawi
Author_xml – sequence: 1
  givenname: Shannon M.
  orcidid: 0000-0003-0321-5974
  surname: Farley
  fullname: Farley, Shannon M.
  email: smf2026@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 2
  givenname: Chunhui
  surname: Wang
  fullname: Wang, Chunhui
  email: cw2551@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 3
  givenname: Rachel M.
  surname: Bray
  fullname: Bray, Rachel M.
  email: Bray0860@gmail.commailto
  organization: ICAP at Columbia University
– sequence: 4
  givenname: Andrea Jane
  orcidid: 0000-0002-7088-4556
  surname: Low
  fullname: Low, Andrea Jane
  email: al3546@cumc.columbia.edu
  organization: Columbia University
– sequence: 5
  givenname: Stephen
  surname: Delgado
  fullname: Delgado, Stephen
  email: delgado.stephen@icloud.com
  organization: ICAP at Columbia University
– sequence: 6
  givenname: David
  surname: Hoos
  fullname: Hoos, David
  email: dh39@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 7
  givenname: Angela N.
  surname: Kakishozi
  fullname: Kakishozi, Angela N.
  email: ank2167@cumc.columbia.edu
  organization: Columbia University
– sequence: 8
  givenname: Tiffany G.
  orcidid: 0000-0003-2212-0874
  surname: Harris
  fullname: Harris, Tiffany G.
  email: th2604@cumc.columbia.edu
  organization: Columbia University
– sequence: 9
  givenname: Rose
  surname: Nyirenda
  fullname: Nyirenda, Rose
  email: nyirendarose@gmail.com
  organization: Malawi Ministry of Health
– sequence: 10
  givenname: Nellie
  surname: Wadonda
  fullname: Wadonda, Nellie
  email: vzn7@cdc.gov
  organization: US Centers for Disease Control and Prevention (CDC)
– sequence: 11
  givenname: Michelle
  surname: Li
  fullname: Li, Michelle
  email: phv9@cdc.gov
  organization: CDC
– sequence: 12
  givenname: Mbaraka
  surname: Amuri
  fullname: Amuri, Mbaraka
  email: ofy5@cdc.gov
  organization: CDC
– sequence: 13
  givenname: James
  surname: Juma
  fullname: Juma, James
  email: jj162us@gmail.com
  organization: Gender, Elderly and Children through The National AIDS Control Program (NACP)
– sequence: 14
  givenname: Nzali
  surname: Kancheya
  fullname: Kancheya, Nzali
  email: yde3@cdc.gov
  organization: CDC
– sequence: 15
  givenname: Ismela
  surname: Pietersen
  fullname: Pietersen, Ismela
  email: oln7@cdc.gov
  organization: CDC
– sequence: 16
  givenname: Nicholus
  surname: Mutenda
  fullname: Mutenda, Nicholus
  email: mutendan@NACOP.NET
  organization: Ministry of Health and Social Services
– sequence: 17
  givenname: Salomo
  surname: Natanael
  fullname: Natanael, Salomo
  email: natanaels@NACOP.NET
  organization: Ministry of Health and Social Services
– sequence: 18
  givenname: Appolonia
  surname: Aoko
  fullname: Aoko, Appolonia
  email: luo7@cdc.gov
  organization: CDC
– sequence: 19
  givenname: Evelyn W.
  surname: Ngugi
  fullname: Ngugi, Evelyn W.
  email: uys7@cdc.gov
  organization: CDC
– sequence: 20
  givenname: Fred
  surname: Asiimwe
  fullname: Asiimwe, Fred
  email: vxv5@cdc.gov
  organization: CDC
– sequence: 21
  givenname: Shirley
  orcidid: 0000-0002-8954-9408
  surname: Lecher
  fullname: Lecher, Shirley
  email: gux5@cdc.gov
  organization: CDC
– sequence: 22
  givenname: Jennifer
  surname: Ward
  fullname: Ward, Jennifer
  email: vzx5@cdc.gov
  organization: CDC
– sequence: 23
  givenname: Prisca
  surname: Chikwanda
  fullname: Chikwanda, Prisca
  email: ooj8@cdc.gov
  organization: CDC
– sequence: 24
  givenname: Owen
  surname: Mugurungi
  fullname: Mugurungi, Owen
  email: mugurungi@gmail.com
  organization: Zimbabwe Ministry of Health and Child Care
– sequence: 25
  givenname: Brian
  surname: Moyo
  fullname: Moyo, Brian
  email: moyobk1@gmail.com
  organization: Zimbabwe Ministry of Health and Child Care
– sequence: 26
  givenname: Peter
  surname: Nkurunziza
  fullname: Nkurunziza, Peter
  email: pn2289@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 27
  givenname: Dorothy
  surname: Aibo
  fullname: Aibo, Dorothy
  email: dae2131@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 28
  givenname: Andrew
  surname: Kabala
  fullname: Kabala, Andrew
  email: ak3969@cumc.columbia.edul
  organization: ICAP at Columbia University
– sequence: 29
  givenname: Sam
  surname: Biraro
  fullname: Biraro, Sam
  email: sb3795@cumc.columbia.edu
  organization: Columbia University
– sequence: 30
  givenname: Felix
  surname: Ndagije
  fullname: Ndagije, Felix
  email: fn2197@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 31
  givenname: Godfrey
  orcidid: 0000-0001-9077-4429
  surname: Musuka
  fullname: Musuka, Godfrey
  email: gnmusuka@hotmail.com
  organization: ICAP at Columbia University
– sequence: 32
  givenname: Clement
  surname: Ndongmo
  fullname: Ndongmo, Clement
  email: cfn2@cdc.gov
  organization: CDC
– sequence: 33
  givenname: Judith
  surname: Shang
  fullname: Shang, Judith
  email: ioz6@cdc.gov
  organization: CDC
– sequence: 34
  givenname: Emily K.
  surname: Dokubo
  fullname: Dokubo, Emily K.
  email: vic8@cdc.gov
  organization: CDC
– sequence: 35
  givenname: Laura E.
  surname: Dimite
  fullname: Dimite, Laura E.
  email: hoz2@cdc.gov
  organization: CDC
– sequence: 36
  givenname: Rachel
  surname: McCullough‐Sanden
  fullname: McCullough‐Sanden, Rachel
  email: rmsanden@gmail.com
  organization: CDC
– sequence: 37
  givenname: Anne‐Cecile
  surname: Bissek
  fullname: Bissek, Anne‐Cecile
  email: annezkbissek@yahoo.fr
  organization: Cameroon Ministry of Public Health
– sequence: 38
  givenname: Yimam
  surname: Getaneh
  fullname: Getaneh, Yimam
  email: yimamgetaneh@gmail.com
  organization: Ethiopia Public Health Institute
– sequence: 39
  givenname: Frehywot
  surname: Eshetu
  fullname: Eshetu, Frehywot
  email: ipk7@cdc.gov
  organization: CDC
– sequence: 40
  givenname: Tepa
  surname: Nkumbula
  fullname: Nkumbula, Tepa
  email: tn2362@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 41
  givenname: Lyson
  surname: Tenthani
  fullname: Tenthani, Lyson
  email: lt2771@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 42
  givenname: Felix R.
  surname: Kayigamba
  fullname: Kayigamba, Felix R.
  email: fk2323@cumc.columbia.edu
  organization: ICAP at Columbia University
– sequence: 43
  givenname: Wilford
  surname: Kirungi
  fullname: Kirungi, Wilford
  email: wkirungi@starcom.co.ug
  organization: Uganda Ministry of Health
– sequence: 44
  givenname: Joshua
  surname: Musinguzi
  fullname: Musinguzi, Joshua
  email: joshuamusinguzi@yahoo.co.uk
  organization: Uganda Ministry of Health
– sequence: 45
  givenname: Shirish
  surname: Balachandra
  fullname: Balachandra, Shirish
  email: ymx1@cdc.gov
  organization: CDC
– sequence: 46
  givenname: Eugenie
  surname: Kayirangwa
  fullname: Kayirangwa, Eugenie
  email: hqr0@cdc.gov
  organization: CDC
– sequence: 47
  givenname: Ayiyi
  surname: Ayite
  fullname: Ayite, Ayiyi
  email: pvq4@cdc.gov
  organization: CDC
– sequence: 48
  givenname: Christine A.
  surname: West
  fullname: West, Christine A.
  email: bwj2@cdc.gov
  organization: CDC
– sequence: 49
  givenname: Stephane
  surname: Bodika
  fullname: Bodika, Stephane
  email: ymx1@cdc.gov
  organization: CDC
– sequence: 50
  givenname: Katrina
  surname: Sleeman
  fullname: Sleeman, Katrina
  email: hhk6@cdc.gov
  organization: CDC
– sequence: 51
  givenname: Hetal K.
  surname: Patel
  fullname: Patel, Hetal K.
  email: byg7@cdc.gov
  organization: CDC
– sequence: 52
  givenname: Kristin
  surname: Brown
  fullname: Brown, Kristin
  email: aoi2@cdc.gov
  organization: CDC
– sequence: 53
  givenname: Andrew C.
  surname: Voetsch
  fullname: Voetsch, Andrew C.
  email: aav6@cdc.gov
  organization: CDC
– sequence: 54
  givenname: Wafaa M.
  surname: El‐Sadr
  fullname: El‐Sadr, Wafaa M.
  email: wme1@cumc.columbia.edu
  organization: Columbia University
– sequence: 55
  givenname: Jessica J.
  surname: Justman
  fullname: Justman, Jessica J.
  email: jj2158@cumc.columbia.edu
  organization: Columbia University
BookMark eNp9kt2K1DAUx4OsuB964xMEBJGFjknatM2NUNaPHVlU0PU2pM1pm6GTjEm7s3vnI_iMPokZZ9AdGSRwTj5-53-SnHOKjqyzgNBTSmaUEPZyYRSbsZwQ_gCd0IKXCcs5O7o3P0anISwIyVmZiUfoOM1pkZOUnKDbT951HkLAo1srr6PvAV9_qOavP2NBfn7_sTN4VL6DMWC1dLbDK_DB2bjqQGNOsLIau0GDx4O5MRFYm7HHl_Ov2FhMU1y13jTK4sZNdvQGwmP0sFVDgCc7f4au3775cnGZXH18N7-orpKG55QnlNYpF6Jpa16qsgDNMtCi0FRlpco0V5QXpC6BsqbNGZC8zHQEMlZngmRpkZ6hV1vd1VQvQTcQ06tBrrxZKn8nnTJy_8SaXnbuRgrOmCjTKPBiJ-DdtwnCKJcmNDAMyoKbgmQFIxnLKRURffYPunCTt_F5kaKCRUPoX6pTA0hjWxfzNhtRWRWpoDRLGYtUcoDqwEK8ZKx_a-L2Hj87wMehYWmagwHP7wX0oIaxD26YRhPrug-eb8HGuxA8tH8-jxK5aUC5aUD5uwEjTLfwOqa7-w8p388rto35BbOE2dU
CitedBy_id crossref_primary_10_3390_microorganisms11102426
crossref_primary_10_1136_bmjopen_2022_069308
crossref_primary_10_1002_jia2_25997
crossref_primary_10_1097_QAD_0000000000003895
crossref_primary_10_7554_eLife_85435
crossref_primary_10_1097_JNC_0000000000000433
crossref_primary_10_2147_HIV_S311613
crossref_primary_10_1159_000530723
crossref_primary_10_1002_jia2_26200
crossref_primary_10_1016_S2352_3018_24_00123_1
crossref_primary_10_1186_s12879_024_09161_y
Cites_doi 10.1186/s12877-018-0941-x
10.1097/QAI.0000000000002702
10.1186/s12939-015-0157-z
10.2147/TCRM.S227290
10.1258/ijsa.2011.011340
10.1097/QAD.0b013e3283560f54
10.1371/journal.pone.0077101
10.1186/s12889-021-10573-7
10.2217/fvl.11.43
10.1186/s12889-020-09457-z
10.1136/sextrans-2018-053925
10.1186/s12889-020-09121-6
10.1371/journal.pone.0162967
10.1093/aje/kwh090
10.1097/QAD.0000000000000479
10.1007/s10461-011-9994-y
10.1371/journal.pone.0194732
10.1097/QAD.0000000000001845
10.7448/IAS.19.1.20673
10.21203/rs.3.rs-61574/v1
10.1016/j.jana.2010.04.002
10.1002/jia2.25239
10.1093/cid/ciu701
10.1097/QAI.0000000000001173
10.1097/QAD.0000000000002355
10.1097/QAD.0b013e3283558513
10.1371/journal.pone.0196158
10.1002/jia2.25470
10.1097/QAD.0000000000002096
10.1097/QAI.0000000000001117
10.1097/QAD.0000000000001870
10.1093/aje/kwg074
10.1177/0898264317751945
10.1097/QAI.0000000000002710
10.1093/ofid/ofx162.137
10.15585/mmwr.mm6701a6
10.1371/journal.pone.0207005
ContentType Journal Article
Copyright 2022 The Authors. published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
COPYRIGHT 2022 John Wiley & Sons, Inc.
2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1002/jia2.26005
DatabaseName Wiley-Blackwell Open Access Collection
Wiley-Blackwell Backfiles (Open access)
CrossRef
ProQuest Central (Corporate)
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: 7X7
  name: ProQuest_Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate Farley SM et al
EISSN 1758-2652
EndPage n/a
ExternalDocumentID A739114322
10_1002_jia2_26005
JIA226005
Genre article
GeographicLocations Africa
Cameroon
United States--US
Rwanda
Tanzania
Zambia
Ivory Coast
California
Kenya
San Francisco California
Eswatini
Malawi
Namibia
Zimbabwe
Uganda
Lesotho
Ethiopia
GeographicLocations_xml – name: Africa
– name: Cameroon
– name: Tanzania
– name: Malawi
– name: Rwanda
– name: Ivory Coast
– name: Namibia
– name: Uganda
– name: United States--US
– name: Eswatini
– name: California
– name: Lesotho
– name: Zimbabwe
– name: San Francisco California
– name: Ethiopia
– name: Kenya
– name: Zambia
GrantInformation_xml – fundername: President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention
  funderid: #1U2GGH000994; 5NU2GGH001226
– fundername: President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention
  grantid: #1U2GGH000994; 5NU2GGH001226
GroupedDBID ---
-5E
-5G
-BR
0R~
1OC
24P
29L
2VQ
2WC
3V.
4.4
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAHHS
ABDBF
ABUWG
ACCFJ
ACGFO
ACGFS
ACRMQ
ACXQS
ADBBV
ADINQ
ADKYN
ADPDF
ADRAZ
ADUKV
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AFGXO
AFKRA
AHBYD
AHMBA
AIAGR
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMKLP
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICW
IEA
IHR
IHW
INH
INR
IOF
ITC
KQ8
M1P
M48
M~E
N8Y
O5R
O5S
O9-
OK1
OVD
OVEED
P2P
PIMPY
PQQKQ
PROAC
PSQYO
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TEORI
TR2
TUS
UKHRP
WIN
AAYXX
CITATION
ABMYL
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c5615-11b3599cfb58a87ed24ed97d1a48a4d5a1570b8e12cf62e0684ded942b4904373
IEDL.DBID RPM
ISSN 1758-2652
IngestDate Tue Sep 17 21:30:34 EDT 2024
Fri Jun 28 07:12:47 EDT 2024
Thu Oct 10 22:52:25 EDT 2024
Fri Feb 23 00:22:19 EST 2024
Sat Oct 26 03:12:58 EDT 2024
Tue Mar 12 03:41:24 EDT 2024
Tue Aug 20 22:08:45 EDT 2024
Thu Sep 12 16:53:45 EDT 2024
Sat Aug 24 00:55:14 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S4
Language English
License Attribution
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5615-11b3599cfb58a87ed24ed97d1a48a4d5a1570b8e12cf62e0684ded942b4904373
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9077-4429
0000-0003-0321-5974
0000-0002-7088-4556
0000-0003-2212-0874
0000-0002-8954-9408
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522983/
PMID 36176030
PQID 2719227101
PQPubID 55048
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9522983
proquest_miscellaneous_2720426119
proquest_journals_2719227101
gale_infotracmisc_A739114322
gale_infotracgeneralonefile_A739114322
gale_infotracacademiconefile_A739114322
gale_healthsolutions_A739114322
crossref_primary_10_1002_jia2_26005
wiley_primary_10_1002_jia2_26005_JIA226005
PublicationCentury 2000
PublicationDate September 2022
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: September 2022
PublicationDecade 2020
PublicationPlace Geneva
PublicationPlace_xml – name: Geneva
– name: Hoboken
PublicationTitle Journal of the International AIDS Society
PublicationYear 2022
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2015; 14
2021; 87
2021; 21
2016; 19
2017; 4
2020; 20
2019; 31
2019; 33
2020; 16
2016; 73
2012; 16
2014; 28
2018; 67
2013; 8
2011; 6
2003; 157
2016; 11
2018; 18
2017; 74
2004; 159
2020; 96
2021
2019; 22
2020
2014; 59
2019
2011; 22
2020; 23
2015
2014
2012; 26
2018; 32
2012; 23
2018; 13
e_1_2_12_4_1
e_1_2_12_6_1
e_1_2_12_19_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_38_1
e_1_2_12_20_1
e_1_2_12_41_1
e_1_2_12_22_1
e_1_2_12_43_1
e_1_2_12_24_1
e_1_2_12_45_1
e_1_2_12_26_1
e_1_2_12_47_1
e_1_2_12_28_1
e_1_2_12_49_1
e_1_2_12_31_1
e_1_2_12_52_1
e_1_2_12_33_1
e_1_2_12_54_1
e_1_2_12_35_1
e_1_2_12_56_1
e_1_2_12_37_1
e_1_2_12_14_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_50_1
e_1_2_12_5_1
e_1_2_12_18_1
e_1_2_12_16_1
Joint United Nationas Programme on HIV/AIDS (UNAIDS) (e_1_2_12_3_1) 2014
e_1_2_12_39_1
e_1_2_12_42_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_23_1
e_1_2_12_25_1
West CA (e_1_2_12_46_1) 2021; 87
e_1_2_12_48_1
e_1_2_12_40_1
e_1_2_12_27_1
e_1_2_12_29_1
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_32_1
e_1_2_12_55_1
e_1_2_12_34_1
e_1_2_12_57_1
e_1_2_12_36_1
e_1_2_12_15_1
e_1_2_12_13_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_9_1
References_xml – volume: 18
  start-page: 257
  issue: 1
  year: 2018
  article-title: HIV testing and counselling experiences: a qualitative study of older adults living with HIV in Western Kenya
  publication-title: BMC Geriatr
– volume: 14
  start-page: 26
  year: 2015
  article-title: Determinants of access to healthcare by older persons in Uganda: a cross‐sectional study
  publication-title: Int J Equity Health
– volume: 157
  start-page: 940
  year: 2003
  end-page: 3
  article-title: Estimating the relative risk in cohort studies and clinical trials of common outcomes
  publication-title: Am J Epidemiol
– volume: 26
  start-page: S85
  issue: 1
  year: 2012
  end-page: 91
  article-title: HIV and Africa's elderly: the problems and possibilities
  publication-title: AIDS
– volume: 22
  issue: 2
  year: 2019
  article-title: Retention on antiretroviral therapy during universal test and treat implementation in Zomba district, Malawi: a retrospective cohort study
  publication-title: J Int AIDS Soc
– volume: 11
  issue: 11
  year: 2016
  article-title: Rising levels of HIV infection in older adults in eastern Zimbabwe
  publication-title: PLoS One
– volume: 13
  issue: 4
  year: 2018
  article-title: ‘I was referred from the other side’: gender and HIV testing among older South Africans living with HIV
  publication-title: PLoS One
– volume: 23
  year: 2020
  article-title: Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90‐90‐90 in sub‐Saharan Africa—a systematic review and meta‐analysis
  publication-title: J Int AIDS Soc
– volume: 32
  start-page: 1551
  issue: 12
  year: 2018
  end-page: 61
  article-title: The transition to dolutegravir and other new antiretrovirals in low‐income and middle‐income countries
  publication-title: AIDS
– volume: 13
  issue: 11
  year: 2018
  article-title: Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000–2020
  publication-title: PLoS One
– volume: 74
  start-page: e9
  year: 2017
  end-page: 17
  article-title: Sexual behaviors and HIV status: a population‐based study among older adults in rural South Africa
  publication-title: J Acquir Immune Defic Syndr
– volume: 19
  issue: 1
  year: 2016
  article-title: Closer to 90‐90‐90. The cascade of care after 10 years of ART scale‐up in rural Malawi: a population study
  publication-title: J Int AIDS Soc
– volume: 59
  start-page: 1787
  issue: 12
  year: 2014
  end-page: 97
  article-title: Cross‐sectional comparison of the prevalence of age‐associated comorbidities and their risk factors between HIV‐infected and uninfected individuals: the AGEhIV cohort study
  publication-title: Clin Infect Dis
– year: 2021
– volume: 16
  start-page: 169
  year: 2020
  end-page: 80
  article-title: HIV treatment outcomes among patients initiated on antiretroviral therapy pre and post‐universal test and treat guidelines in South Africa
  publication-title: Ther Clin Risk Manag
– volume: 31
  start-page: 709
  issue: 4
  year: 2019
  end-page: 32
  article-title: How to ‘Live a Good Life’: aging and HIV testing in rural South Africa
  publication-title: J Aging Health
– volume: 26
  start-page: S1
  issue: 01
  year: 2012
  end-page: 5
  article-title: Aging with HIV in Africa: the challenges of living longer
  publication-title: AIDS
– volume: 33
  start-page: 349
  year: 2019
  end-page: 52
  article-title: Where are the positives? HIV testing in sub‐Saharan Africa in the era of test and treat
  publication-title: AIDS
– volume: 33
  start-page: s213
  issue: 3
  year: 2019
  end-page: 26
  article-title: Global, regional and country‐level 90‐90‐90 estimates for 2018: assessing progress towards the 2020 target
  publication-title: AIDS
– volume: 159
  start-page: 702
  year: 2004
  end-page: 6
  article-title: A modified Poisson regressions approach to prospective studies with binary data
  publication-title: Am J Epidemiol
– year: 2014
– volume: 20
  start-page: 970
  year: 2020
  article-title: HIV epidemic and cascade of care in 12 east African rural fishing communities: results from a population‐based survey in Uganda
  publication-title: BMC Public Health
– volume: 28
  start-page: S453
  issue: 4
  year: 2014
  end-page: 9
  article-title: Increasing trends in HIV prevalence among older people aged 50 years and older: evidence from estimates and survey data
  publication-title: AIDS
– volume: 73
  start-page: e33
  issue: 2
  year: 2016
  end-page: 5
  article-title: Sex differences in mortality and loss among 21,461 older adults on antiretroviral therapy in sub‐Saharan Africa
  publication-title: J Acquir Immune Defic Syndr
– volume: 23
  start-page: 490
  issue: 7
  year: 2012
  end-page: 6
  article-title: HIV prevalence and sexual behavior at older ages in rural Malawi
  publication-title: Int J STD AIDS
– volume: 6
  start-page: 755
  issue: 6
  year: 2011
  end-page: 67
  article-title: A missing piece of the puzzle: HIV in mature adults in sub‐Sharan Africa
  publication-title: Future Virol
– volume: 87
  start-page: S5
  issue: 1
  year: 2021
  end-page: 15
  article-title: Population‐based HIV Impact Assessments Survey methods, response, and quality in Zimbabwe, Malawi, and Zambia
  publication-title: J Acquir Immune Defic Syndr
– volume: 8
  issue: 10
  year: 2013
  article-title: Recent patterns in population‐based HIV prevalence in Swaziland
  publication-title: PLoS One
– volume: 4
  start-page: S58
  year: 2017
  article-title: Leveraging the ART advantage: diabetes and hypertension along the HIV care cascade in rural South Africa
  publication-title: Open Forum Infect Dis
– volume: 87
  start-page: S17
  year: 2021
  end-page: 27
  article-title: A comprehensive approach to assuring quality of laboratory testing in HIV surveys: lessons learned from the population‐based HIV impact assessment project
  publication-title: J Acquir Immune Defic Syndr
– volume: 21
  start-page: 650
  issue: 1
  year: 2021
  article-title: ‘Too Old to Test?’: a life course approach to HIV‐related risk and self‐testing among midlife‐older adults in Malawi
  publication-title: BMC Public Health
– year: 2020
– volume: 87
  start-page: S197
  year: 2021
  end-page: 06
  article-title: Unawareness of HIV infection among men aged 15–59 years in 13 sub‐Saharan African countries: findings from the population‐based HIV impact assessments, 2015–2019
  publication-title: J AIDS
– volume: 20
  start-page: 1375
  year: 2020
  article-title: Towards achieving the 90‐90‐90 HIV targets: results from the south African 2017 national HIV survey
  publication-title: BMC Public Health
– volume: 16
  start-page: 63
  year: 2012
  end-page: 8
  article-title: HIV attitudes, awareness and testing among older adults in Africa
  publication-title: AIDS Behav
– volume: 32
  start-page: 1563
  year: 2018
  end-page: 9
  article-title: Achieving the fourth 90: healthy aging for people living with HIV
  publication-title: AIDS
– volume: 96
  start-page: 271
  year: 2020
  end-page: 6
  article-title: HIV treatment cascade for older adults in rural South Africa
  publication-title: Sex Transm Infect
– volume: 13
  issue: 3
  year: 2018
  article-title: Sexual behavior experiences and characteristics of male–female partnerships among HIV positive adolescent girls and young women: qualitative findings from Zimbabwe
  publication-title: PLoS One
– year: 2019
– volume: 67
  start-page: 29
  year: 2018
  end-page: 32
  article-title: Status of HIV epidemic control among adolescent girls and young women aged 15–24 years – seven African countries, 2015–2017
  publication-title: Morb Mortal Wkly Rep
– volume: 22
  start-page: 17
  issue: 1
  year: 2011
  end-page: 25
  article-title: Ageing with HIV: a cross‐sectional study of comorbidity prevalence and clinical characteristics across decades of life
  publication-title: J Assoc Nurses AIDS
– year: 2015
– ident: e_1_2_12_43_1
  doi: 10.1186/s12877-018-0941-x
– ident: e_1_2_12_27_1
– ident: e_1_2_12_34_1
  doi: 10.1097/QAI.0000000000002702
– volume: 87
  start-page: S197
  year: 2021
  ident: e_1_2_12_46_1
  article-title: Unawareness of HIV infection among men aged 15–59 years in 13 sub‐Saharan African countries: findings from the population‐based HIV impact assessments, 2015–2019
  publication-title: J AIDS
  contributor:
    fullname: West CA
– ident: e_1_2_12_48_1
  doi: 10.1186/s12939-015-0157-z
– ident: e_1_2_12_57_1
  doi: 10.2147/TCRM.S227290
– ident: e_1_2_12_21_1
– ident: e_1_2_12_11_1
  doi: 10.1258/ijsa.2011.011340
– ident: e_1_2_12_39_1
  doi: 10.1097/QAD.0b013e3283560f54
– ident: e_1_2_12_5_1
– ident: e_1_2_12_13_1
  doi: 10.1371/journal.pone.0077101
– ident: e_1_2_12_42_1
  doi: 10.1186/s12889-021-10573-7
– ident: e_1_2_12_20_1
– ident: e_1_2_12_12_1
  doi: 10.2217/fvl.11.43
– ident: e_1_2_12_16_1
  doi: 10.1186/s12889-020-09457-z
– ident: e_1_2_12_31_1
– ident: e_1_2_12_14_1
  doi: 10.1136/sextrans-2018-053925
– volume-title: 90‐90‐90: an ambitious treatment target to help end the AIDS epidemic
  year: 2014
  ident: e_1_2_12_3_1
  contributor:
    fullname: Joint United Nationas Programme on HIV/AIDS (UNAIDS)
– ident: e_1_2_12_15_1
  doi: 10.1186/s12889-020-09121-6
– ident: e_1_2_12_23_1
– ident: e_1_2_12_26_1
– ident: e_1_2_12_8_1
  doi: 10.1371/journal.pone.0162967
– ident: e_1_2_12_35_1
  doi: 10.1093/aje/kwh090
– ident: e_1_2_12_7_1
  doi: 10.1097/QAD.0000000000000479
– ident: e_1_2_12_38_1
  doi: 10.1007/s10461-011-9994-y
– ident: e_1_2_12_4_1
– ident: e_1_2_12_29_1
– ident: e_1_2_12_45_1
  doi: 10.1371/journal.pone.0194732
– ident: e_1_2_12_55_1
  doi: 10.1097/QAD.0000000000001845
– ident: e_1_2_12_17_1
  doi: 10.7448/IAS.19.1.20673
– ident: e_1_2_12_53_1
  doi: 10.21203/rs.3.rs-61574/v1
– ident: e_1_2_12_51_1
  doi: 10.1016/j.jana.2010.04.002
– ident: e_1_2_12_56_1
  doi: 10.1002/jia2.25239
– ident: e_1_2_12_47_1
  doi: 10.1093/cid/ciu701
– ident: e_1_2_12_32_1
– ident: e_1_2_12_41_1
  doi: 10.1097/QAI.0000000000001173
– ident: e_1_2_12_6_1
  doi: 10.1097/QAD.0000000000002355
– ident: e_1_2_12_24_1
– ident: e_1_2_12_40_1
  doi: 10.1097/QAD.0b013e3283558513
– ident: e_1_2_12_44_1
  doi: 10.1371/journal.pone.0196158
– ident: e_1_2_12_10_1
  doi: 10.1002/jia2.25470
– ident: e_1_2_12_37_1
  doi: 10.1097/QAD.0000000000002096
– ident: e_1_2_12_52_1
  doi: 10.1097/QAI.0000000000001117
– ident: e_1_2_12_54_1
– ident: e_1_2_12_9_1
  doi: 10.1097/QAD.0000000000001870
– ident: e_1_2_12_36_1
  doi: 10.1093/aje/kwg074
– ident: e_1_2_12_50_1
  doi: 10.1177/0898264317751945
– ident: e_1_2_12_19_1
  doi: 10.1097/QAI.0000000000002710
– ident: e_1_2_12_49_1
  doi: 10.1093/ofid/ofx162.137
– ident: e_1_2_12_22_1
– ident: e_1_2_12_18_1
  doi: 10.15585/mmwr.mm6701a6
– ident: e_1_2_12_30_1
– ident: e_1_2_12_28_1
– ident: e_1_2_12_33_1
– ident: e_1_2_12_25_1
– ident: e_1_2_12_2_1
  doi: 10.1371/journal.pone.0207005
SSID ssj0062849
Score 2.4143014
Snippet Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV)...
Abstract Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of...
Introduction: Achieving optimal HIV outcomes, as measured by global 90?90?90 targets, that is awareness of HIV?positive status, receipt of antiretroviral (ARV)...
Introduction: Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV)...
Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among...
IntroductionAchieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV)...
INTRODUCTIONAchieving optimal HIV outcomes, as measured by global 90-90-90 targets, that is awareness of HIV-positive status, receipt of antiretroviral (ARV)...
SourceID pubmedcentral
proquest
gale
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Publisher
StartPage e26005
SubjectTerms Acquired immune deficiency syndrome
Age groups
ageing
AIDS
AIDS (Disease)
AIDS research
Antiretroviral agents
Care and treatment
Demographic aspects
Demographics
Evaluation
Health status indicators
HIV
HIV epidemiology
HIV infection
HIV testing
Households
Human immunodeficiency virus
Laboratories
Older people
older PLHIV
PHIA
Population
Public health administration
Self report
UNAIDS goals
Women
SummonAdditionalLinks – databaseName: ProQuest_Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fi9QwEA96vgginn-wep4jioJQr0nTJnk6ltNj98BD0JV9C22TvVuR7urugY9-BD-jn8SZpFutyr20XTKFkvmTmdmZ3zD2TJRzcsx5qgqFAYooTarxlEidVEZ74UrlqMH57Wk5nsqTWTHrEm7rrqxyaxODoXbLhnLkB0KhL4KXjB-uvqQ0NYr-Xe1GaFxl17hA4UV5VrM-4CrR9JoeklQcfFpU4hUBsheDQ-hvU_xveeSfbms4d45vsZudwwijyOFddsW3t9mNmG2D2ER0h317R2VWaLRgE8pg8X7uYXo6mrx-Dyb7-f1Hd4FY-b2GMGQIVsHfxl9n3kGRQdU6WNLcbvi8oEwDUJoWxpOPsGiB5xCnCrUQJkxQkH2XTY_ffDgap91MhbRBT6lIOa_zwphmXhe60so7Ib0zyvFK6kq6ouKFymrtuWjmpfBZqaVDAilqaQIM0j220y5bf59Bzmups7zJ8IacFRhL67nzHC0mhmGlStjT7SbbVYTOsBEkWVhihQ2sSNhj2n8b2z57fbMjlaMdlmhvEvYiUJDGIT-aqmscwK8g7KoB5fMB5VlE7v4f4d6AEFWqGS5vhcF2Kr22vwUwYU_6ZXqTytRav7wgGhFiUm4SpgZC1O8AwXkPV9rFeYD1NugKG50n7GUQt0v2zJ5MRiI8Pbj8Sx-y64LaNUJN3B7b2Xy98I_QidrU-0FTfgFL0BnY
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9qfRFE6hdGq64oCkLa7GY3u_sgcqjlrmAR9KRvIcnutScl148r1Df_BP9G_xJndnOh0SK-5IOdQDIzOzuzmfkNwAtRzMgx56lWGgMUUdjU4CqROqmt8cIV2lGB88e9YjyVu_tqfw1W_Ts7Bp5dGdpRP6np6dHWxcn3tzjh33QAotvf5pXYIqB1dQ2uCwLkohQ-2f9NKNAE21AYqVArCiV6mNLLzw4Wpj_N898pk5dd2bAW7WzArc6JZKMo9duw5ts7cDPuwLFYWHQXLj5R6hUaMrYMqbF4PvRsujeavP_MbPbrx8_uwGI2-BkLjYfYcfDB8e7AO6YyVrWOLaiXNzua0-4Do61bNp58ZfOW8ZzFTkMtC10nKPC-B9OdD1_ejdOuz0LaoPekUs7rXFnbzGplKqO9E9I7qx2vpKmkUxVXOquN56KZFcJnhZEOCaSopQ3QSPdhvV20_gGwnNfSZHmT4QmlLTC-NjPnOVpRDM0KncDzFZPL4winUUbgZFGSKMogigSeEv_LWAraz8FypHO0zRJtUAKvAgXpBcqjqbpiAnwLwrMaUL4cUB5ENO-rCDcHhDjNmuHwShnKlZaWQqODjIeMJ_CsH6YnKXWt9YtzohEhTuU2AT1Qop4DBPE9HGnnhwHq26J7bE2ewOugbv_gWbk7GYlw9fB_v_gR3BBUzBEy5jZhfXl67h-ji7Wsn4T58xtRsiGE
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley-Blackwell Open Access Collection
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9qfRGkWD8wba0rioIQm93sZnfBl0MtdwVLQU_6FpLsXnsiudK7go_-Cf6N_iXO7OZSoyL4kg92AmG-dmaZ-Q3AM1HMKDDnqVYaExRR2NTgLpE6qa3xwhXaUYPz--NiPJVHp-p0A16ve2EiPkR_4EaWEfw1GXhVLw-uQUM_zyvxiuDV1Q24SZAxpN9Cnqz9cIGO14Z2SIW6UCjRg5OKg-tvB9vR7075z0LJXwPYsAMd3oGtLnRkoyjrbdjw7V24Hc_dWGwnugdfT6jgCt0XW4WCWLyfezY9Hk3efmA2-_Hte3dhsQZ8ycK4IXYRIm98O_OOqYxVrWMLmuDNvszpzIHRgS0bTz6xect4zuJ8oZaFWROUbt-H6eG7j2_GaTddIW0wZlIp53WurG1mtTKV0d4J6Z3VjlfSVNKpClma1cZz0cwK4bPCSIcEUtTSBkCkB7DZLlr_EFjOa2myvMnwhjIWmFWbmfMcfScmZIVO4OmayeVFBNEoI1yyKEkUZRBFAo-J_2VsAO0trxzpHD2yRM-TwItAQbaH8miqroUA_4JQrAaUzweUZxHD-2-EewNCNK5muLxWhrIz7mUpNIbFeMl4Ak_6ZfqSCtZav7giGhGyU24T0AMl6jlAwN7DlXZ-HgC-LQbF1uQJvAzq9g-elUeTkQhPO_9DvAu3BLVxhFq5PdhcXV75Rxhcrer9YEM_AYd3HE4
  priority: 102
  providerName: Wiley-Blackwell
Title Progress towards the UNAIDS 90‐90‐90 targets among persons aged 50 and older living with HIV in 13 African countries
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjia2.26005
https://www.proquest.com/docview/2719227101
https://search.proquest.com/docview/2720426119
https://pubmed.ncbi.nlm.nih.gov/PMC9522983
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED-t4wUJIf6KbKMYgUBCShs7Tmw_hrGpndSqAjpVvERJ7G5BW1ptncQjH4HPyCfh7CTVAogHXuxEviiWfXe-s353B_CaxUtrmFNfRAIdFBYrX-Ip4WsulDRMx0LbAOfJNB7N-ckiWuxA1MbCONB-kZeD6uJyUJXnDlu5viyGLU5sOJscKjQalAyHPeghg7Yueq1-Y9S3apuHlA2_lhkb2CzstkZNiOd17BDPtw6h31Xxn_DI22arO3eOH8D9xmAkST2xh7Bjqkdwr75tI3UQ0WP4NrMwK1RaZONgsNifGzKfJuMPn4gKfn7_0TSkRn5fE1dkiKydvY1vZ0aTKCBZpcnK1u0mF6W9aSD2mpaMxqekrAgNSV1VqCKuwoR1sp_A_Pjo8-HIb2oq-AVaSpFPaR5GShXLPJKZFEYzbrQSmmZcZlxHGY1EkEtDWbGMmQliyTUScJZz5dIgPYXdalWZZ0BCmnMZhEWAHe4sQ19aLrWhqDHRDYuFB6_aRU7XdeqMtE6SzFK7K6nbFQ9e2PVP67DPrbyliQhRD3PUNx68dRRW4nA_iqwJHMBZ2NxVHco3HcqzOnP33wgPOoQoUkV3uGWGtBHp65QJNIaxCagHL7fD9ksLU6vM6sbSMOeTUuWB6DDRdgVsOu_uCHK5S-vdcLUH7xy7_WPN0pNxwtzT3n__Zh_uMhvJ4eByB7C7uboxz9G-2uR96DE-w1YsRB_uJKfzL3Ps3x9NZx_77s4C2wmXfSd3vwBx0CnT
link.rule.ids 230,315,730,783,787,867,888,11576,12070,21402,24332,27938,27939,31735,31736,33760,33761,43326,43821,46068,46492,50830,50939,53808,53810,74083,74640
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELdgPICEEH9FxmCHQCAhZYsdJ7afUAVM7dgqJFbUNyuJ3a0IpR3tJB75CHxGPgl3ThoIoL0kqXyRIt8f313vfsfYc5HPyDHnscoUBigiN7HGUyJ2UhnthcuVowbn43E-nMjDaTZtE26rtqxyYxODoXaLinLk-0KhL4KXhL9ensc0NYr-XW1HaFxl1wiHiyRcTbuAK0fTazpIUrH_eV6IPQJkz3qH0N-m-N_yyD_d1nDuHNxmt1qHEQYNh--wK76-y2422TZomojusW8fqMwKjRasQxks3s88TMaD0duPYJKf33-0F2gqv1cQhgzBMvjb-OvUO8gSKGoHC5rbDV_mlGkAStPCcPQJ5jXwFJqpQjWECRMUZN9nk4N3J2-GcTtTIa7QU8pizss0M6aalZkutPJOSO-McryQupAuK3imklJ7LqpZLnySa-mQQIpSmgCD9IBt1YvaP2SQ8lLqJK0SvCFnBcbSeuY8R4uJYViuIvZss8l22UBn2AYkWVhihQ2siNgu7b9t2j47fbMDlaIdlmhvIvYyUJDGIT-qom0cwK8g7Koe5Yse5WmD3P0_wp0eIapU1V_eCINtVXplfwtgxJ52y_QmlanVfnFBNCLEpNxETPWEqNsBgvPur9TzswDrbdAVNjqN2KsgbpfsmT0cDUR42r78S3fZ9eHJ8ZE9Go3fP2I3BLVuhPq4Hba1_nrhH6NDtS6fBK35Bb3RHMo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwED9BJyEkhPgrMgYzAoGEFBo7Tmw_ocJWtQOqCijam5XEzlY0pYV2Eo98BD4jn4Sz4xYCaC9JKl-kyOc737m_-x3AE5bXLjCnscgEJigsV7HEXSI2XChpmcmFcQXO7yb5aMaPjrPjgH9aBVjlxid6R20WlTsj7zOBsQheEtqvAyxiejB8ufwSuw5S7p_W0E7jMuwInvOkBzuvDifT9xu_nKMjVluCUtb_PC_YC0fPnnW2pL8d879gyT-DWL8LDW_A9RA-kkGr75twyTa34Fp79kbakqLb8G3qQFfowsjag2LxfmrJbDIYH3wgKvn5_Ue4kBYHviK-5RBZ-ugbf51YQ7KEFI0hC9fFm5zN3bkDcYe2ZDT-ROYNoSlpeww1xPebcCn3HZgNDz--HsWhw0JcYdyUxZSWaaZUVZeZLKSwhnFrlDC04LLgJitoJpJSWsqqOmc2ySU3KMBZyZUnRboLvWbR2HtAUlpymaRVgjfUM8PMWtbGUvSfmJTlIoLHm0nWy5ZIQ7eUyUw7VWivigj23fzrtgh0a316IFL0yhy9TwTPvISzP9RHVYQyAvwKx2TVkXzakTxpebz_J7jXEUQDq7rDm8Wgg4Gv9O_lGMGj7bB704HWGrs4dzLMZ6hURSA6i2g7A47cuzvSzE89ybfCwFjJNILnfrldMGf6aDxg_mn34i_dhytoMvrtePLmPlxlro7Dg-X2oLf-em4fYHS1Lh8Gs_kFBOYiZA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+towards+the+UNAIDS+90%E2%80%9090%E2%80%9090+targets+among+persons+aged+50+and+older+living+with+HIV+in+13+African+countries&rft.jtitle=Journal+of+the+International+AIDS+Society&rft.au=Farley%2C+Shannon+M&rft.au=Wang%2C+Chunhui&rft.au=Bray%2C+Rachel+M&rft.au=Low%2C+Andrea+Jane&rft.date=2022-09-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1758-2652&rft.eissn=1758-2652&rft.volume=25&rft_id=info:doi/10.1002%2Fjia2.26005&rft.externalDocID=A739114322
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-2652&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-2652&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-2652&client=summon